Brief: Egetis Therapeutics Resolves On Directed Issues Of Warrants, Convertible Bond

Egetis Therapeutics AB (publ)

07/11/2023 07:27

Nov 7 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * EGETIS THERAPEUTICS HAS RESOLVED ON DIRECTED ISSUES OF
WARRANTS
AND A CONVERTIBLE BOND WITHIN THE FRAMEWORK OF THE DRAWDOWN OF
TRANCHE A OF THE PREVIOUSLY COMMUNICATED DEBT FINANCING
    * CONVERTIBLE BOND WILL BE SUBSCRIBED FOR BY PAYMENT OF ITS
NOMINAL AMOUNT OF EUR 3 MILLION
    * CONVERTIBLE BOND CONVERSION PRICE HAS BEEN SET TO
APPROXIMATELY
EUR 0.5133 PER SHARE

Source text for Eikon:  ID:nMFN7G0rtY 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))